iValiD-TB: A fully characterized Mycobacterium tuberculosis dataset for antimicrobial resistance bioinformatics workflow validations

For clinical assay validations, well-characterized samples are essential for assessing methodology sensitivity and specificity. To support the community in the development of clinical next-generation sequencing assays for Mycobacterium tuberculosis, we released a comprehensive dataset of 50 whole genome sequences from characterized strains, complete with drug susceptibility and mutation profiles.